Clinical Effectiveness and Safety of Vericiguat in Worsening Heart Failure with Reduced Ejection Fraction: A Single-center, Retrospective Analysis in Indian Patients

Background and Objective: In a tertiary care hospital in India, investigators evaluated the efficacy and safety of vericiguat, a new oral soluble guanylate cyclase stimulator in patients with worsening symptoms of heart failure and reduced ejection fraction (HFrEF). Methods: A retrospective assessme...

תיאור מלא

שמור ב:
מידע ביבליוגרפי
Main Authors: Pankaj Jariwala, Avvaru Guru Prakash, Poondru Rohith Reddy, Dilip Gude, Gururaj Pramod Kulkarni, Arshad Punjani, Harikishan Boorugu, Dilip Babu Madhawar, Anusha Jariwala
פורמט: Artigo
שפה:Inglês
יצא לאור: Wolters Kluwer Medknow Publications 2025-01-01
סדרה:Journal of the Practice of Cardiovascular Sciences
נושאים:
cardiovascular mortality
hospitalization for heart failure
soluble guanylyl cyclase
vericiguat
worsening heart failure
גישה מקוונת:https://journals.lww.com/10.4103/jpcs.jpcs_63_24
תגים: הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!

פריטים דומים